Medicare Covers Next Generation Sequencing Tests for Advanced Cancer
The Centers for Medicare & Medicaid Services Friday issued a to cover diagnostic laboratory tests using next generation sequencing for certain Medicare patients with advanced cancer. 鈥淭hese tests can help doctors consult with patients about more targeted care or enrollment in a clinical trial,鈥 CMS Chief Medical Officer Kate Goodrich, M.D. 鈥淭he expanded coverage in this final [national coverage determination] now includes additional tests for relapsed, refractory and earlier stage III cancers to aid in the treatment of these cancer patients.鈥
Related News Articles
Headline
A report released June 17 by NORC at the University of Chicago, commissioned by the Coalition to Strengthen America鈥檚 Healthcare, found that patients enrolled鈥
Headline
The Centers for Medicare and Medicaid Services May 30 released a notice requesting comments on a proposed Medicare Advantage service level data collection鈥
Headline
The AHA commented to the Centers for Medicare & Medicaid Services June 10 on the fiscal year 2026 inpatient prospective payment system proposed rule (https鈥
Headline
The AHA expressed concerns (LINK) to the Centers for Medicare & Medicaid Services today on payment updates for the fiscal year 2026 proposed rule for the鈥
Headline
The AHA commented on proposed changes to the Transforming Episode Accountability Model, a new, mandatory, episode-based payment model scheduled to begin Jan. 1鈥
Headline
The AHA June 10 commented on the fiscal year 2026 inpatient psychiatric facility proposed rule, expressing support for several provisions such as increases in鈥